ProfileGDS4718 / 240116_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 54% 52% 50% 54% 53% 45% 46% 53% 53% 54% 47% 54% 49% 45% 45% 49% 49% 50% 47% 60% 47% 47% 52% 50% 48% 44% 52% 49% 66% 47% 46% 43% 57% 53% 44% 44% 49% 51% 52% 43% 52% 48% 46% 42% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.742854
GSM549102patient 115, normal, homogenized [OPG study]5.6777652
GSM549104patient 119, normal, homogenized [OPG study]5.483450
GSM549108patient 138, normal, homogenized [OPG study]5.7829154
GSM549119patient 077, normal, homogenized [OPG study]5.7054153
GSM549133patient 032, cancer, homogenized [OPG study]5.1998445
GSM549139patient 042, cancer, homogenized [OPG study]5.288946
GSM549099patient 107, normal, homogenized [OPG study]5.6911553
GSM549109patient 139, normal, homogenized [OPG study]5.7129953
GSM549110patient 046, normal, homogenized [OPG study]5.738854
GSM549114patient 063, normal, homogenized [OPG study]5.2776247
GSM549122patient 082, normal, homogenized [OPG study]5.7449354
GSM549134patient 033, cancer, homogenized [OPG study]5.4274349
GSM549136patient 036, cancer, homogenized [OPG study]5.1975445
GSM549140patient 044, cancer, homogenized [OPG study]5.2054845
GSM549111patient 047, normal, homogenized [OPG study]5.4513849
GSM549113patient 057, normal, homogenized [OPG study]5.3816249
GSM549132patient 031, cancer, homogenized [OPG study]5.5128350
GSM549137patient 038, cancer, homogenized [OPG study]5.3086947
GSM549142patient 047, cancer, homogenized [OPG study]6.2042860
GSM549100patient 110, normal, homogenized [OPG study]5.3681447
GSM549107patient 135, normal, homogenized [OPG study]5.3080147
GSM549115patient 068, normal, homogenized [OPG study]5.580552
GSM549116patient 072, normal, homogenized [OPG study]5.483450
GSM549120patient 078, normal, homogenized [OPG study]5.3844548
GSM549131patient 030, cancer, homogenized [OPG study]5.1453244
GSM549118patient 074, normal, homogenized [OPG study]5.6416252
GSM549129patient 027, cancer, homogenized [OPG study]5.4893649
GSM549123patient 088, normal, homogenized [OPG study]6.5562466
GSM549124patient 006, cancer, homogenized [OPG study]5.3665647
GSM549126patient 015, cancer, homogenized [OPG study]5.2814146
GSM549128patient 025, cancer, homogenized [OPG study]5.120543
GSM549103patient 117, normal, homogenized [OPG study]5.9787357
GSM549117patient 073, normal, homogenized [OPG study]5.6148653
GSM549138patient 041, cancer, homogenized [OPG study]5.1760644
GSM549141patient 045, cancer, homogenized [OPG study]5.1489344
GSM549130patient 028, cancer, homogenized [OPG study]5.479449
GSM549101patient 111, normal, homogenized [OPG study]5.5779351
GSM549105patient 128, normal, homogenized [OPG study]5.6242752
GSM549106patient 134, normal, homogenized [OPG study]5.0945543
GSM549112patient 048, normal, homogenized [OPG study]5.597152
GSM549125patient 011, cancer, homogenized [OPG study]5.4268248
GSM549127patient 024, cancer, homogenized [OPG study]5.2769346
GSM549135patient 035, cancer, homogenized [OPG study]5.0503842